For Patient Awaiting New Heart, a Ventricular Assist Device Brings Hope

Michigan Medicine patient Eddie Craig is thankful for the heart pump that is keeping him alive until he can undergo a transplant.

7:00 AM

Author | Jane Racey Gleeson

Eddie Craig was only 25 when his life took a drastic and unexpected turn.

In April 2015, while on the job as a security guard, Craig felt run-down and short of breath. Later in his shift, Craig's co-workers recommended he go home to rest.

MORE FROM MICHIGAN: Sign up for our weekly newsletter

Instead, Craig drove to an emergency room near his home in Detroit. He was diagnosed with pneumonia and admitted for treatment.

When his symptoms didn't improve, doctors performed more tests and made a far different discovery: Craig was experiencing congestive heart failure due to a form of cardiomyopathy known as nonischemic dilated cardiomyopathy (DCM).

DCM is a condition in which the heart becomes enlarged and can't pump blood efficiently to the rest of the body. This decreased heart function can affect the kidneys, lungs, liver and other body systems.

Symptoms of congestive heart failure include shortness of breath, fatigue, swelling in the legs, ankles or abdomen, persistent coughing, nausea and elevated heart rate.

Unable to provide the necessary care, doctors referred Craig to the University of Michigan Frankel Cardiovascular Center, where his life-threatening cardiomyopathy was confirmed.

After an evaluation, the cardiology team determined Craig was a candidate for a ventricular assist device (VAD).

How a VAD works

A VAD is a mechanical circulatory support therapy, or heart pump, used in patients with advanced heart failure who meet certain medical criteria.

SEE ALSO: Living for Years Without a Heart Is Now Possible

"Patients who are eligible for a VAD have advanced heart failure that does not improve with medical therapy," says Rena Lucier, R.N., a VAD coordinator at the Frankel Cardiovascular Center.

"Often, the patients we see referred for a VAD are unable to carry out basic activities for daily living such as bathing and dressing themselves," Lucier says. "They are unable to walk even short distances before having to stop and catch their breath."

VADs help to pump blood from the left ventricle (the left lower chamber of the heart) into the aorta, the main vessel that carries blood from the heart to the rest of the body.

Implanted inside the body, the pump is connected to a cord known as a "driveline" that exits through a small site in the abdomen. The driveline is connected to a small computer, called the controller, which is attached to batteries and runs the pump.

A VAD can be used in two ways: as a bridge to heart transplant in patients who meet the qualifications for a transplant but need temporary support to survive until a donor heart becomes available, and as destination therapy for patients with advanced heart failure who may not be eligible for a heart transplant.

As destination therapy, VADs are implanted permanently as long-term support to extend a patient's life.

'The right choice'

Despite feelings of fear and uncertainty, Craig knew a VAD was his only hope for survival until a suitable heart could be found.

The VAD was implanted in February 2016. Craig, now 27, has since learned to live with the device.

"The U-M team did a wonderful job explaining my VAD, so I was confident that I could manage it after leaving the hospital," he says. "At first, I was depressed because of my new reliance on the device, but as time went on I appreciated that it was keeping me alive."

He is grateful for a second chance at life. And he's keeping a positive attitude during the wait.

Says Craig: "I know I made the right choice."

Photo by Leisa Thompson

More Articles About: Heart Health Cardiomyopathy Heart Failure LVADs, VADs and Other Assist Devices Cardiovascular: Diseases & Conditions
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]


Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Featured News & Stories smart watch on wrist
Health Lab
Clinical smart watch finds success at identifying atrial fibrillation
A Michigan Medicine research team developed a prescription wristwatch that continuously monitors the wearer’s heart rhythm and uses a unique algorithm to detect atrial fibrillation. The clinical-grade device, called the Verily Study Watch, proved very accurate at identifying atrial fibrillation in participants.
supar molecule teal blue yellow red
Health Lab
Immune protein suPAR links viral infection as possible cause of kidney disease
Through a series of experiments in non-human primates, mice and humans, a multi-institutional team led by researchers from Michigan Medicine and Rush University found that the immune protein soluble urokinase plasminogen activator receptor, or suPAR, is an important link between viral infections and proteinuria; the elevation of protein in the urine is known to cause glomerulopathy, a common form of kidney disease.
heart organ yellow blue
Health Lab
Irregular heartbeat after valve surgery increases risk of stroke, death
Postoperative atrial fibrillation, commonly known as Afib, has traditionally been viewed as benign and limited. But a study led by researchers at the University of Michigan Health Frankel Cardiovascular Center finds that postoperative atrial fibrillation increases the risk of strokes and permanent Afib — and is linked to worse long term survival — after heart valve surgery.
human organ for transplant
Health Lab
Findings shed light on how a pediatric heart surgery complication impacts heart transplant survival
Patients who experience this condition following the Fontan continue to have a high risk of death from the time they’re waitlisted for a new heart through receiving the transplant, according to a 20-center study led by Michigan Medicine. And one specific complication called cyanosis – or experiencing less than normal oxygen blood levels – was associated with worsened survival.
Brain image highlighting areas
Health Lab
Women stroke survivors believe they will receive worse care in the emergency room
National study examined health care perceptions of approximately 3,500 women, including those with and without a history of stroke
surgeons in OR with blue and teal scrubs with screen on and patient under teal sheet
Health Lab
Treating heart valve disease: What are your options?
Michigan Medicine’s head of cardiac surgery, Gorav Ailawadi, M.D, M.B.A., answers questions about different treatment options for heart valve disease.